[The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
Offerhaus
L
L
D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D002544:Cerebral Infarction / Q000517:prevention & control*; D004176:Dipyridamole / Q000008:administration & dosage* / Q000009:adverse effects; D019317:Evidence-Based Medicine; D005378:Financial Support; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D014665:Vasodilator Agents / Q000008:administration & dosage*
D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D004176:Dipyridamole; D001241:Aspirin